Arcutis Biotherapeutics GAAP EPS of $0.11 beats by $0.08, revenue of $129.8M beats by $10.95M
Arcutis Biotherapeutics reported GAAP EPS of $0.11, beating the estimate of $0.08, and revenue of $129.8 million, exceeding expectations by $10.95 million.
Although the stock experienced a short-term pullback immediately after the announcement of strong earnings news, we considered entering based on the fact that, as of 2026-08-28, the trading volume was 1.43 times the 20-day average volume.
Given the rebound momentum from strong earnings, if the stock price rises and reaches the profit‑taking target of $29.84, we will take profit; if the downtrend continues and the price falls below the stop‑loss level of $25.63, we will execute a stop‑loss.
At the entry point, the RSI(14) is at 38.1, indicating an oversold condition; the moving averages are misaligned; trading volume is 1.43 times the 20‑day average, and the recent 7‑day change rate is -4.8%.
Although VEEE (return 451.7%), LRCX (return 346.8%), and AMD (return 333.8%) lack direct similarity evidence, they have been identified as past similar cases for reference to global top performance.
Although the earnings release posted a surprise beat on both GAAP EPS and revenue, prompting an entry with expectations of a positive rebound, the stock ultimately broke its stop‑loss level of $25.63 and closed with a –12.3% FAILED rating. At the time of entry, the RSI(14) stood at 38.1, indicating an oversold condition, and volume was 1.43 times the 20‑day average. However, the moving‑average misalignment and a recent 7‑day volatility of –4.8% reflected stronger downside pressure, and the technical backdrop was not sufficiently defended.
Through this trade, I learned that even if there is a strong short‑term catalyst like an earnings surprise, a conservative approach is needed when the moving averages are misaligned and a downtrend persists. Going forward, when entering based on positive earnings catalysts, I will not only consider increased volume and RSI oversold signals but also comprehensively assess whether the moving averages are turning into alignment and the trend in the number of news items related to the theme (falling), thereby tightening stop‑loss criteria.